Traditional Chinese medicine effervescent tablets for treating gynecologic inflammations and preparation method thereof
A technology for gynecological inflammation and effervescent tablets, which can be used in medical formulas, medical preparations containing active ingredients, antipyretics, etc. It can solve problems such as high cost, inconvenient transportation and storage, and inability to extract them, so as to achieve high utilization rate The effect of increasing and improving drug efficacy and reducing production cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] The preparation of the medicated powder of embodiment 1 treatment gynecological inflammation
[0041] Raw material formula: Huanglian 248g, Sophora flavescens 100g, Patrinia 10g, Borneol 7g.
[0042] Preparation method: (1) Take Huanglian and Sophora flavescens, extract 3 times with 88% ethanol, each time for 2 hours, filter, and use the dregs for later use, add β-cyclodextrin 60g, PVPk to the filtrate 30 60g and poloxamer 10g, mix well, recover ethanol under reduced pressure, and obtain the concentrated solution of alcohol extraction; take the dregs of the medicine and add water to decoct 2 times, each time for 1.5 hours, filter, and the filtrate is centrifuged at high speed, and the centrifugate is concentrated to a relative density of 1.23( 60°C), combined with the alcohol extraction concentrate, spray-dried and pulverized to obtain the extract powder of Huanglian Sophora flavescens;
[0043] (2) Take borneol, 56g of β-cyclodextrin, and refer to the method [So...
Embodiment 2
[0046] The preparation of the medicated powder of embodiment 2 treatment gynecological inflammation
[0047] Raw material formula: Huanglian 210g, Sophora flavescens 120g, Patrinia 12g, Borneol 8g.
[0048] Preparation method: (1) get Huang Lian, pulverize into coarse powder, sterilize, and superfinely pulverize into ultrafine powder with a particle diameter≤10um to obtain Huanglian superfine powder;
[0049] (2) Take Sophora flavescens, extract 2 times with 95% ethanol, each time for 2.5 hours, filter, and the dregs are for subsequent use, and the filtrate is added with PVPk 30 70g, 30g of hydroxypropyl methylcellulose (HPMC-E5), 8g of soybean lecithin, stir well, recover ethanol under reduced pressure, concentrate to obtain alcohol extraction concentrate; take the dregs and add water to decoct twice, 1 hour each time , filtered, the filtrate was centrifuged at high speed, the centrifugate was concentrated to a relative density of 1.38, combined with the concentrated a...
Embodiment 3
[0052] The preparation of the medicated powder of embodiment 3 treatment gynecological inflammation
[0053] Raw material formula: Huanglian 218g, Sophora flavescens 110g, Patrinia 13g, Borneol 6g.
[0054] Preparation method: (1) get Huang Lian, pulverize into coarse powder, sterilize, and superfinely pulverize into ultrafine powder with a particle diameter≤10um to obtain Huanglian superfine powder;
[0055] (2) Take Sophora flavescens, extract 3 times with petroleum ether, each time for 1.5 hours, filter, use dregs for later use, combine filtrates, recover petroleum ether under reduced pressure, add PEG to the residue 6000 80g, 30g of hydroxypropyl-β-cyclodextrin, 5g of lecithin, 550ml of ethanol, after heating to reflux for 40min, recover ethanol under reduced pressure, freeze-dry, and crush at low temperature to obtain the fine powder of solubilized matter of Sophora flavescens fat-soluble extract; The dregs are decocted twice with water, each time for 1.5 hours, fi...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap